OMB
OMB Home White House Website

Agency:    Department of Defense--Military
Bureau:    Research, Development, Test, and Evaluation
Account:    Research, development, test, and evaluation, Army (21-2040)
Certifying Official:    Deputy Comptroller Program/Budget
Contact Information:    http://WWW.DOD.GOV   703-697-5131
Cancer Vaccine (Note: only for continued development of molecular switching vaccines using genetically modified Listera for cancer, infectious diseases and bio-defense)

1 recipient will receive $3,257,000. This is a continuing earmark.
Year Enacted: 2005
Description: Cancer Vaccine (for Continued Development of Molecular Switching Vaccines Using Genetically Modified Listeria for Cancer, Infectious Disease and Bio-Defense); FY05 DoD Appropriations Conference Report 108-622, page 257, Cancer Vaccine $3,400,000
 
Beneficiary/Recipient Amount ($K) Program Type Address
Cerus Corporation $3,257 For-Profit
Concord, CA
Citation
Source: Appropriations Report Language - Conference
Reference: 108-622
Location: Line 31, Page 257
Citation Excerpt: Cancer Vaccine (Note: only for continued development of molecular switching vaccines using genetically modified Listera for cancer, infectious diseases and bio-defense)

Last Modified: 16-Apr-2007

Federal Register    |   Jobs at OMB   |   FOIA   |  OMB Locator   |   USA.gov   |   Accessibility   |   Privacy Policy   |   Site Search   |   Help